The influence of thyroid hormone medication on the intra-therapeutic half-life of 131I during radioactive iodine treatment of solitary toxic thyroid nodules

  • Lorenz, R., Buck, A. & Reiners, C. Inpatient nuclear medicine therapy in Germany from 2010 to 2012: Analysis of structured quality reports. Nuklearmedizin 5461–68 (2015).

    CAS Google Scholar Article

  • Spilker, L., Happel, C., Döbert, N. & Grünwald, F. Is radioactive iodine therapy conducted too late in patients with thyroid autonomy?. Nuklearmedizin 478–12 (2008).

    CAS Google Scholar Article

  • Doan, O. et al. The sodium/iodine symporter (NIS): Characterization, regulation and medical significance. Endocr. Round. 2448–77 (2003).

    CAS Google Scholar Article

  • Norden, MM et al. The downregulation of the sodium/iodide symporter explains 131Thyroid dizziness induced by I. Cancer Res. 677512–7517 (2007).

    Google Scholar article

  • Clerc, J. Radioactive iodine therapy of thyroid autonomy. QJ Nucl. Med. Mol. Imaging. 65138-156 (2021).

    Google Scholar article

  • Happel, C. et al. Correction of hyperfunctional radiation-induced stunning (CHRIS) in benign thyroid disease. Endocrine 66466–473 (2020).

    Google Scholar article

  • Topić Vučenović, V. et al. Population exposure-response model 131I in patients with mild thyroid disease. EUR. J.Pharm. Science. 165105942. https://doi.org/10.1016/j.ejps.2021.105942 (2021).

    CAS PubMed Google Scholar Article

  • Verburg, FA Is thyroid surgery performed too often in Germany?. Nuklearmedizin 54101-105 (2015).

    Google Scholar article

  • Hertz, S., Roberts, A. & Salter, WT Iodine metabolism in Graves’ disease. J.Clin. Invest. 2125–29 (1942).

    CAS Google Scholar Article

  • Dietlein, M., Eschner, W., Lassmann, M., Hänscheid, H., Verburg, FA, Luster, M.: 031-012.

  • Dietlein, M. et al. Radioactive iodine therapy for benign thyroid disease (version 5) [German Guideline]. Nuklearmedizin 55213-220 (2016).

    Google Scholar article

  • Li, J. et al. Effectiveness of radiofrequency ablation according to the types of benign thyroid nodules. Science. representing 11(1), 22270. https://doi.org/10.1038/s41598-021-01593-9 (2021).

    ADS CAS PubMed Article PubMed Central Google Scholar

  • Korkusuz, Y. et al. Thermal ablation of thyroid nodules: are radiofrequency ablation, microwave ablation, and high-intensity focused ultrasound such safe and effective methods?. EUR. Radiol. 28929–935 (2018).

    Google Scholar article

  • De la Vieja, A. & Riesco-Eizaguirre, G. Radioiodine treatment: from molecular aspects to clinical view. Cancer 13995 (2021).

    Google Scholar article

  • Hanscheid, H. et al. EANM Dosimetry Committee Series on Standard Operating Procedures for Pre-Therapeutic Dosimetry II: Dosimetry Prior to Radioiodine Therapy of Benign Thyroid Disease. EUR. J. Nucl. Med. Mol. Imaging 401126-1134 (2013).

    Google Scholar article

  • Happel, C. et al. Focus on the biokinetics of radioactive iodine 131: The influence of methylprednisolone on the effective intratherapeutic half-life of 131I during radioactive iodine therapy for Graves’ disease. Endocrine 73125-130 (2021).

    CAS Google Scholar Article

  • Köhrle, J. & Schmutzler, C. Wie kommt Jod in die Schilddrüse? Neues zum Natrium-Iodid-Symporter (NIS). Internist 39560–565 (1998).

    Google Scholar article

  • Ekholm, R. & Bjorkman, U. Localization of iodine binding in the thyroid gland in vitro. Endocrinology 1151558-1567 (1984).

    CAS Google Scholar Article

  • Ramos, CD et al. Thyroid suppression test with L-thyroxine and [99mTc] pertechnetate. Clin. Endocrinol. 52471–477 (2000).

    CAS Google Scholar Article

  • Bockisch, A., Sonnenschein, W., Jentzen, W., Hartung, V. & Görges, R. Dosimetry in radioactive iodine therapy in benign thyroid disease context and practice. Nuklearmedizin 31253–262 (2008).

    Google Scholar article

  • Marinelli, L., Quinby, E. & Hine, G. Dosage determination with radioactive isotopes. Practical considerations in therapy and protection. A m. J. Roentgenol. 59260-281 (1948).

    CAS Google Scholar

  • Rokni, H., Sadeghi, R., Moossavi, Z., Treglia, G. & Zakavi, SR Efficacy of different radioactive iodine therapy protocols for the treatment of toxic nodular goiter: a systematic review and meta-analysis of the literature. Int. J. Endocrinol. Metabol. 12e14424 (2018).

    Google Scholar

  • Strahlenschutz in der Medizin – Richtlinie zur Verordnung über den Schutz vor Schäden durch ionisierende Strahlen (Strahlenschutzverordnung – StrlSchV). Gemeinsames Ministerialblatt 2011, S. 867).

  • Das, D., Banerjee, A., Jena, AB, Duttaroy, AK, and Pathak, S. Essentiality, relevance, and efficacy of adjuvant/combination therapy in the management of thyroid dysfunction. Biomedical. Pharmacologist. 146112613. https://doi.org/10.1016/j.biopha.2022.112613 (2022).

    CAS PubMed Google Scholar Article

  • Barbaro, D. et al. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: efficacy for ablation of post-surgical remnants and possible role of L-thyroxine iodine content in the outcome of removal. J.Clin. Endocrinol. Metab. 884110–4115 (2003).

    CAS Google Scholar Article

  • Bockisch, A., Jamitzky, T., Derwanz, R. & Biersack, HJ Optimized dose planning of radioactive iodine therapy for benign thyroid disease. J. Nucl. Med. 341632–1638 (1993).

    CAS PubMed Google Scholar

  • Nüchel, C., Boddenberg, B. & Schicha, H. The importance of radioactive iodine testing for calculating therapeutic dose in benign thyroid disease. Nuklearmedizin 3291–98 (1993).

    Google Scholar article

  • Canzi, C., Zito, F., Voltini, F., Reschini, E. & Gerundini, P. Verification of agreement of two dosimetric methods with radioactive iodine therapy in hyperthyroid patients. Med. Phys. 332860–2867 (2006).

    CAS Google Scholar Article

  • Bogner, L. & Czempiel, H. Approximation errors in physical planning for radioactive iodine therapy of the thyroid. Nuklearmedizin 32236–246 (1993).

    CAS Google Scholar Article

  • Van Isselt, JW, de Klerk, JM, Koppeschaar, HP & Van Rijk, PP The rate of uptake and turnover of iodine-131 varies over short intervals in Graves’ disease. Nucl. Med. Common. 21609-616 (2000).

    Google Scholar article

  • Sisson, JC, Avram, AM, Lawson, SA, Gauger, PG & Doherty, GM The so-called stunning of thyroid tissue. J. Nucl. Med. 471406–1412 (2006).

    CAS PubMed Google Scholar

  • About Michael Bill

    Check Also

    Maltese Fibromyalgia and M/E Activist Shows How Much Medication She Needs to Function

    Ruth Debono, Malta’s fibromyalgia leader and M/E campaigner, showed people how much medicine she needs …